Journal of the Practice of Cardiovascular Sciences

: 2020  |  Volume : 6  |  Issue : 1  |  Page : 12--15

Cardiology update 2020 first quarter

Satyavir Yadav 
 Department of Cardiology, AIIMS, New Delhi, India

Correspondence Address:
Satyavir Yadav
Department of Cardiology, Cardio Neuro Center, AIIMS, Room No. 32, 7thFloor, New Delhi

This review covers the end of 2019 and the beginning of 2020 and includes treatment of asymptomatic aortic stenosis, role of antisense oligonucleotides, rivaroxaban in transcatheter aortic valve implantation (TAVI), complete revascularization after myocardial infarction (MI) proving superior, study of colchicine in MI, and update of NOBLE trial showing that percutaneous coronary intervention in left main interventions is inferior to coronary artery bypass graft. There were also a number of trials highlighting various aspects of the outcomes of TAVI implants.

How to cite this article:
Yadav S. Cardiology update 2020 first quarter.J Pract Cardiovasc Sci 2020;6:12-15

How to cite this URL:
Yadav S. Cardiology update 2020 first quarter. J Pract Cardiovasc Sci [serial online] 2020 [cited 2020 Aug 14 ];6:12-15
Available from:;year=2020;volume=6;issue=1;spage=12;epage=15;aulast=Yadav;type=0